血管紧张素Ⅱ受体拮抗剂的研究应用进展
卢荣枝
摘要(Abstract)：
血管紧张素Ⅱ (AngⅡ )受体拮抗剂主要通过阻断AngⅡ与受体的结合而达到抗高血压的作用。由于其疗效显著 ,与血管紧张素转换酶抑制剂 (ACEI)疗效相当 ,但本类药不影响与激肽分解相关的激肽酶Ⅱ活性 ,很少导致与ACEI类似的刺激性干咳和咽、喉、呼吸道、肺等致命性血管神经性水肿 ,因此受到临床的重视。现对AngⅡ受体拮抗剂的研究应用进展作一综述 ,以供参考。
关键词(KeyWords)：
血管紧张素Ⅱ;受体拮抗剂;研究应用进展
基金项目(Foundation):
作者(Author):
卢荣枝
参考文献(References)：
- 1CodyRJ.TheClinicalpotentialofrenininhibitorsandan giotensinantagonists.Drug . 1994,47:5 86
- 2MacfadyenRJ,Reid .JL .Angiotensinreceptorantagonistsasatreatmentforhypertensin .JHypertension . 1994,12 (12 )1333～ 1338
- 3JohnstonCL ,NaitohM ,BurrellLM .RationaleandpharmacologyofangiotensinⅡreceptorantagonists:Currentstatusandfutureis sues.Jhypertension . 1997,15 (Supp17) :S3～S6
- 4SmithRd ,SweetCS ,GoldbergA ,etal.Losartanpotassi um :anonpeptideantagonistofangiotensinⅡ .DrugsToday .1995 ,31(7) :46 3
- 5JohnstonCL .Angiotensinreceptorantagonists:focusonlosar tan .Lancet. 1995 ,346 :140 3
- 6GoaKL ,WagstaffAJ .Losartanpotassium :Areviewofitspharmacologyclinicalefficacyandtolerabilityinthemanagementofhypertension .Drug . 1996 ,5 1:82 0
- 7CriscioneL ,GasparoM ,BuhlmayerP ,etal.Pharmacologyprofileofvalsartan :apotentorallyactive.Nonpeptideantago nistofangiotensinⅡAT1receptorsubtype.BritishJPharma cology. 1993,110 :76 1
- 8CorenL ,CardoniO ,FogariR ,etal.Valsartan ,Anewan giotensinⅡantagonistforthetreatmentofessentialhyperten sion :Acomparativestudyoftheefficacyandsafetyagainstam lodipine.ClinPharmacolThera . 1996 ,6 0 :341
- 9RuilopeL .Humanpharmacokinetic/pharmacodynamicprofileofirbesartan ,anewpotentangiotensinⅡreceptorantagonist.JHypertensin . 1997,15 (Suppl 7) :S15～S2 0
- 10郭利 .抗高血压药物依贝沙坦的药效学和药代动力学及临床应用 .国外医学药学分册 . 1998,2 5 (4 ) :2 12
- 11刘淑红 .血管紧张素Ⅱ阻滞剂伊贝沙坦和坎地沙坦 .国外医学药学分册 . 1998,2 5 (4 ) 2 46
- 12McClellanKJ,BalfoutrJA .Eprosartan .Drugs. 1998,5 5(5 ) :713
- 13张衡 .血管紧张素Ⅱ受体拮抗剂他索沙坦 .药学进展 .1998,2 2 (2 ) :118
- 14McClellanKJ,MarkhamA .Telmisartan .Drug . 1998,5 6(6 ) :10 39
- 15VanHeiningenPNM ,VANLierJJ ,deBruinH ,etal.sin gledosestudyonthepharmacodynamicsandpharmacokineticsoftheangiotensinⅡantagonistBIBR0 2 77SE .PharmacyWorldScience. 1994,16 (Supp1) :4